Literature DB >> 30982142

Very late-onset flap margin corneal ulcer following laser in situ keratomileusis.

Gilad Rabina1, Nur Azem1, Michael Mimouni2,3, Idan Hecht4, David Varssano1.   

Abstract

PURPOSE: To report and characterize cases of very late onset (5 years or more after surgery) flap margin corneal ulcers after laser in situ keratomileusis (LASIK) procedure.
METHODS: A retrospective case series of consecutive patients who were diagnosed with very late flap margin corneal ulcers following LASIK, between January 2014 and July 2017. All patients were treated with topical antibiotics and were followed up until complete resolution.
RESULTS: A total of eight patients, with a mean age of 46.5 ± 11 years, (range 31-64 years), were included in this study. All patients underwent uneventful myopic LASIK 13.3 ± 3 (range 10-20) years before presentation. Patients best corrected visual acuity (BCVA) at presentation was 0.20 ± 0.15 logMAR compared to a final BCVA of 0.10 ± 0.10 logMAR (p = 0.28). The ulcer was located in the bottom two clock hours of the flap margin (5-7 o'clock) in six (75%) patients and superior (11 o'clock) in the remaining two patients (p = 0.048). Seven patients (87.5%) suffered from blepharitis, and only one did not.
CONCLUSIONS: LASIK may be associated with an increased risk of late-onset corneal ulcer occurring years after the procedure. Instability of the flap margin, blepharitis and dry eye are possible causes of epithelial disturbance and may account for this complication.

Entities:  

Keywords:  Blepharitis; Corneal ulcer; Dry eye; LASIK; Late complication

Mesh:

Year:  2019        PMID: 30982142     DOI: 10.1007/s10792-019-01100-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  36 in total

1.  The predictability of corneal flap thickness and tissue laser ablation in laser in situ keratomileusis.

Authors:  V D Durairaj; J Balentine; G Kouyoumdjian; J A Tooze; D Young; L Spivack; M J Taravella
Journal:  Ophthalmology       Date:  2000-12       Impact factor: 12.079

2.  Flap complications associated with lamellar refractive surgery.

Authors:  R T Lin; R K Maloney
Journal:  Am J Ophthalmol       Date:  1999-02       Impact factor: 5.258

Review 3.  ASCRS White Paper: Management of infectious keratitis following laser in situ keratomileusis.

Authors:  Eric D Donnenfeld; Terry Kim; Edward J Holland; Dimitri T Azar; F Rick Palmon; Jonathan B Rubenstein; Sheraz Daya; Sonia H Yoo
Journal:  J Cataract Refract Surg       Date:  2005-10       Impact factor: 3.351

4.  Identification of fibrin/fibrinogen in glaucoma filtration surgery wounds.

Authors:  H D Jampel; J Morrison; M Vocci; H Quigley
Journal:  Ophthalmic Surg       Date:  1988-08

5.  Filtering bleb thrombolysis with tissue plasminogen activator.

Authors:  J R Ortiz; S D Walker; P E McManus; L A Martinez; R H Brown; G J Jaffe
Journal:  Am J Ophthalmol       Date:  1988-11-15       Impact factor: 5.258

6.  Pseudomonas keratitis 4 years after laser in situ keratomileusis.

Authors:  Consuelo Ferrer; Jose L Rodriguez-Prats; José L Abad; Pascual Claramonte; Jorge L Alió; Isabel Signes-Soler
Journal:  Optom Vis Sci       Date:  2011-10       Impact factor: 1.973

Review 7.  Infections following laser in situ keratomileusis: an integration of the published literature.

Authors:  Margaret A Chang; Sandeep Jain; Dimitri T Azar
Journal:  Surv Ophthalmol       Date:  2004 May-Jun       Impact factor: 6.048

8.  Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment.

Authors:  Michael A Lemp; Kelly K Nichols
Journal:  Ocul Surf       Date:  2009-04       Impact factor: 5.033

9.  Late-onset laser in situ keratomileusis-related corneal ulcer--a case series.

Authors:  David Varssano; Michael Waisbourd; Lior Berkner; Michael Regenbogen; Rossen Hazarbassanov; Adi Michaeli
Journal:  Cornea       Date:  2009-06       Impact factor: 2.651

10.  Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases.

Authors:  T Bourcier; F Thomas; V Borderie; C Chaumeil; L Laroche
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.